John P. Feighner
Corporate Officer/Principal at University of California San Diego
John P. Feighner active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of California San Diego | Corporate Officer/Principal | 04/02/2010 | - |
| Chief Tech/Sci/R&D Officer | 04/02/2010 | 08/02/2010 |
Career history of John P. Feighner
Former positions of John P. Feighner
| Companies | Position | Start | End |
|---|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Director/Board Member | 30/09/1999 | 01/01/2006 |
| Charter Hospital of Indianapolis | Chief Tech/Sci/R&D Officer | 01/01/1995 | 01/01/1995 |
| Institute for Creation Research | Chief Tech/Sci/R&D Officer | 01/01/1992 | 01/01/1992 |
| Founder | 01/01/1992 | 01/01/1992 | |
| Corporate Officer/Principal | 01/01/1992 | 01/01/1992 | |
| San Luis Rey Equine Hospital | Chief Tech/Sci/R&D Officer | 01/01/1988 | 01/01/1988 |
| Feighner Research Institute | Founder | - | - |
| President | - | - |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
| Feighner Research Institute | |
| San Luis Rey Equine Hospital | |
| Charter Hospital of Indianapolis | |
| Institute for Creation Research |
- Stock Market
- Insiders
- John P. Feighner
- Experience